MEASuRE: Metreleptin Effectiveness And Safety Registry
Status: Recruiting
Location: See all (28) locations...
Intervention Type: Drug
Study Type: Observational
SUMMARY
The study is a post-authorization, prospective, voluntary registry of patients treated with commercial metreleptin including, but not limited to, patients in the US and EEA.
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:
• Patients treated with metreleptin through commercial supply at the time or before enrolment into registry
• Patients who provide a written consent
• Patient coming off metreleptin clinical studies and continuing or restarting treatment with metreleptin through commercial supply
Locations
United States
Alabama
University Alabama at Birmingham
TERMINATED
Birmingham
California
City of Hope
TERMINATED
Duarte
Georgia
Atlanta Diabetes Associates
RECRUITING
Atlanta
Illinois
Ann & Robert H. Lurie Children's Hospital of Chicago
RECRUITING
Chicago
Kansas
University of Kansas Medical Center Research Institute, Inc.
RECRUITING
Kansas City
Louisiana
Children's Hospital of New Orleans/LSU Health Sciences Center
COMPLETED
New Orleans
Ochsner Clinic Foundation
WITHDRAWN
New Orleans
Maryland
Nih/Niddk/Deob
RECRUITING
Bethesda
Michigan
University of Michigan
RECRUITING
Ann Arbor
Childrens Hospital of Michigan
RECRUITING
Detroit
New York
Richmond University Medical Centre
COMPLETED
Staten Island
Ohio
Endocrinology Research Associates
RECRUITING
Columbus
Pennsylvania
Children's Hospital of Philadelphia
RECRUITING
Philadelphia
University of Pennsylvania
WITHDRAWN
Philadelphia
Texas
UT Southwestern Medical Center
RECRUITING
Dallas
Washington
Seattle Children's Hospital
RECRUITING
Seattle
Other Locations
France
CHRU Hôpital Claude Huriez
RECRUITING
Lille
Hôpital Robert Debré
RECRUITING
Paris
Hôpital Saint-Antoine
RECRUITING
Paris
Germany
Kinderkrankenhaus Auf der Bult
NOT_YET_RECRUITING
Hanover
Universitaetsklinikum Leipzig AoeR
RECRUITING
Leipzig
Universitaetsklinikum Muenster
RECRUITING
Münster
Universitaetsklinikum Ulm
RECRUITING
Ulm
Italy
Alma Mater Studiorum - Università di Bologna
RECRUITING
Bologna
Universita del Piemonte Orientale Amedeo Avogadro
RECRUITING
Novara
Azienda Ospedaliero Universitaria Pisana (Presidio di Cisanello)
RECRUITING
Pisa
Azienda Ospedaliera Universitaria Policlinico Tor Vergata
WITHDRAWN
Roma
United Kingdom
Addenbrooke's Hospital
RECRUITING
Cambridge
Contact Information
Primary
Lori Hartnett
clinicaltrials_info@chiesi.com
+3905212791
Time Frame
Start Date: 2016-10-11
Estimated Completion Date: 2031-10-31
Participants
Target number of participants: 100
Treatments
Metreleptin
Metreleptin new-users~Metreleptin prevalent users
Authors
Related Therapeutic Areas
Sponsors
Leads: Aegerion Pharmaceuticals, Inc.